Shares Investor Evening (London)

Shares Investor Evening (London)

Wednesday 18 September 2019

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies.

The event on Wednesday 18 September 2019 in London will include:

• An opportunity for you to talk directly with the directors and ask your questions about the companies’ core strengths and their short and long-term business strategy

• Meet fellow investors and share your investing experience

• Complimentary drinks and snacks

More about the companies presenting:

Mercia Asset Management (MERC) (Formerly Mercia Technologies) The change of name reflects the evolution of the Group's core competencies as a proactive, regionally-focused specialist asset manager.

Open Orphan (ORPH) a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe.

ReNeuron Group (RENE) ReNeuron Group is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

+ More to be announced...

Who Should Attend

The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors. 

Evening timings

18.00
Registration and coffee
18.30
Presentations
Martin Glanfield, CFO - Mercia Fund Management (MERC)
Dr. Mark Payton, CEO - Mercia Fund Management (MERC)
Maurice Treacy, CCO - Open Orphan (ORPH)
Michael Hunt, CFO - ReNeuron Group (RENE)
20.00
Drinks reception and canap├ęs
21.00
Close

Venue

Novotel Tower Bridge, London EC3N 2NR

Sponsored by

Featured Companies